Evidence map›Paper›PMID 39435396›Full record

ArticleGlobal epidemiology2024

Improving the integration of epidemiological data into human health risk assessment: What risk assessors told us they want.

Carl V Phillips, Igor Burstyn, David J Miller, Ali K Hamade, Raghavendhran Avanasi, Denali Boon, Saumitra V Rege, Sandrine E Déglin

Erratum issuedAbstract read
In one paragraph

Article in Global epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Carl V PhillipsEpiphi Consulting, Nashua, NH, United States of America.
Igor BurstynDepartment of Environmental and Occupational Health, Drexel University, Philadelphia, PA, United States of America.
David J MillerU.S. Environmental Protection Agency (retired), United States of America.
Ali K HamadeOregon Health Authority, Portland, OR, United States of America.
Raghavendhran AvanasiSyngenta Crop Protection, LLC., Greensboro, NC, United States of America.
Denali BoonGradient Corp, Boston, MA, United States of America.
Saumitra V RegeExxonMobil Biomedical Sciences Inc., Annandale, NJ, United States of America.
Sandrine E DéglinHealth and Environmental Sciences Institute, Washington, DC, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the practical contributions of epidemiology studies is to inform risk assessment and management to protect public health. However, there is a perception among some that environmental and occupational epidemiology is falling short of satisfying the needs of risk assessors. The specific reasons for this are not clearly understood. To help identify the points of dissatisfaction and possible areas for mutual learning, we conducted a survey of risk assessors, seeking their opinions of epidemiology research. We present a few quantitative measures and a thematic analysis of responses to open-ended questions. Survey results suggest that some risk assessors (with some adamant exceptions) believe that epidemiology has great potential to contribute to risk assessment but can be deficient in many ways. For example, respondents identified the lack of full disclosure of methods, deficiencies in exposure assessment, the absence of comprehensive uncertainty analyses, and the failure to investigate or explore thresholds of effects as some of the common shortcomings. These could be straightforward to address. Respondents also brought up a wide collection of more complicated and subtle concerns that could lead to further improvement of useful results. We identify areas where mutually-educating interdisciplinary dialogue seems particularly promising. Epidemiology research is expensive, and risk management decisions even more so; therefore, it is desirable for the risk assessment and epidemiologic communities to work toward making epidemiologic research more useful for informing decisions.

Indexed as

Risk assessment

Identifiers

PMID39435396
PMCPMC11492098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.